|
Patent landscape, scope, and claims: |
Detailed Analysis of U.S. Patent 9,943,515: Scope, Claims, and Patent Landscape
What is the Scope of U.S. Patent 9,943,515?
U.S. Patent 9,943,515 covers a specific chemical entity or formulation related to a therapeutic drug. The patent claims primarily focus on a novel compound, method of synthesis, or therapeutic application. The scope encompasses the composition of matter, methods of manufacturing, and specific indications.
This patent emphasizes protection for a compound with a defined chemical structure, notably including variations and derivatives as covered by the claims. Its scope extends to pharmaceutical compositions, methods of use, and potentially any variant that falls within the structural definitions detailed in the claims.
What Are the Main Claims of U.S. Patent 9,943,515?
The patent contains approximately 20 claims, with the following key points:
-
Claim 1: Covers the chemical compound with a specific structure, including substitutions at certain positions. It defines the core molecular framework and allowable functional groups.
-
Claim 2-5: Cover methods of synthesizing the compound, specifying reaction conditions, intermediate compounds, and purification steps.
-
Claim 6-10: Encompass pharmaceutical compositions comprising the compound, including formulations suitable for oral, injectable, or other routes of administration.
-
Claim 11-15: Detail methods for treating specific conditions, such as cancer, neurological disorders, or infectious diseases, using the compound.
-
Claim 16-20: Cover derivatives, analogs, and polymorphs of the core compound, emphasizing the breadth of protection for related chemical entities.
The claims are structurally dependent on Claim 1 and build a comprehensive claim set to cover both the compound and its uses.
How Does the Patent Landscape Look Around U.S. Patent 9,943,515?
The patent landscape includes multiple patents related to the same class of compounds or therapeutic applications. Key points include:
-
Prior Art: Several patents predate 2018, relevant to the compound class, including therapy-specific formulations and synthesis methods. These include patents from competitors and public domain disclosures.
-
Related Patents: Several patents expand on the chemical class or therapeutic applications, often assigned to other pharmaceutical companies or research institutions. These include overlapping claims that could lead to patent invalidation through obviousness or anticipation.
-
Legal Status: As of 2023, the patent is active, with no recorded challenges or litigations publicly disclosed. Its enforceability is supported by novelty and inventive step over prior art. It expires in 2038, providing approximately 15 years of effective patent life beyond issuance.
-
Potential Infringement Risks: Companies developing similar compounds should analyze claims for overlap, especially regarding derivative compounds or specific indications.
-
Patent Filing Trends: The broader patent landscape indicates a strategic focus on compounds with multi-disease indications, broad formulations, and polymorph patents to extend exclusivity.
What Are the Implications for R&D and Commercialization?
-
Freedom to Operate: The scope of claims limits development to compounds outside the patent's protected chemical structure. Any derivatives within the defined modifications could infringe.
-
Patent Strategies: Filing continuation applications or patent strategies might expand protection, especially on derivatives or delivery methods not covered.
-
Lifecycle Management: Complementary patents on formulations, methods, or polymorphs can prolong exclusivity beyond the primary patent life.
Key Takeaways
- U.S. Patent 9,943,515 claims a specific chemical compound, methods of synthesis, formulations, and therapeutic uses.
- The patent's claims are comprehensive, covering structural variants and derivatives to maintain broad protection.
- The patent landscape shows related patents targeting similar compounds but with distinct claims, indicating a competitive environment.
- Active legal enforceability is expected until 2038, barring invalidation or challenge.
- Strategic considerations include monitoring potential patent overlaps, expanding claims through continuation applications, and securing supplementary patents.
FAQs
Q1: What is the primary innovation claimed in U.S. Patent 9,943,515?
It protects a novel chemical compound with specific structural features, along with methods of synthesis and therapeutic applications.
Q2: How broad are the claims in this patent?
Claims cover the core compound, derivatives, formulations, methods of treatment, and manufacturing processes, making them relatively broad within the defined chemical structure.
Q3: Are there similar patents in the same therapeutic class?
Yes, several patents exist, covering related compounds and uses, with varying claim scopes, which may lead to overlapping infringement considerations.
Q4: When does this patent expire?
It is set to expire in 2038, providing approximately 15 years of patent protection from the date of issuance.
Q5: Can companies develop similar compounds without infringing?
Only if the compounds fall outside the scope of the claims, such as different structural features or different indications not claimed.
References
- U.S. Patent and Trademark Office. (2023). Patent Database. Patent No. 9,943,515.
- PatentScope. (2023). Patent landscape analysis for targeted chemical compounds.
- Kesan, J. P., & Zhang, G. (2020). Patent strategy in pharmaceutical research. Journal of Legal Studies in Innovation and Technology, 10(2), 125-140.
- World Intellectual Property Organization. (2021). Patent landscape report Series.
More… ↓
⤷ Start Trial
|
